Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity.
暂无分享,去创建一个
S. Iwanaga | H. Umeyama | T. Miyata | A. Bezeaud | M. Guillin | R. Aruga
[1] A. Yoshioka,et al. Factor IX Amagasaki: a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities. , 1991, Biochemistry.
[2] J. Nishioka,et al. Localization of thrombomodulin-binding site within human thrombin. , 1990, The Journal of biological chemistry.
[3] R. Huber,et al. The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989, The EMBO journal.
[4] B. Furie,et al. Molecular defects of factor IX Chicago-2 (Arg 145----His) and prothrombin Madrid (Arg 271----cys): arginine mutations that preclude zymogen activation. , 1989, Blood.
[5] K. Mann,et al. Substitution of valine for glycine-558 in the congenital dysthrombin thrombin Quick II alters primary substrate specificity. , 1989, Biochemistry.
[6] K. Mann,et al. Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382. , 1988, Biochemistry.
[7] J. Elion,et al. Functional characterization of thrombin Salakta: an abnormal thrombin derived from a human prothrombin variant. , 1988, Blood.
[8] S. Iwanaga,et al. PROTHROMBIN TOKUSHIMA: A REPLACEMENT OF ARGININE-418 BY TRYPTOPHAN THAT IMPAIRS THE FIBRINOGEN CLOTTING ACTIVITY OF DERIVED THROMBIN TOKUSHIMA , 1987, Thrombosis and Haemostasis.
[9] B. Furie,et al. Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273. , 1986, The Journal of biological chemistry.
[10] C. Soria,et al. Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin. , 1984, Thrombosis research.
[11] R. MacGillivray,et al. Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. , 1983, Biochemistry.
[12] Y. Sakata,et al. Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[13] Andrew Dearing,et al. Studies of nucleotide conformations and interactions. The relative stabilities of double‐helical B‐DNA sequence isomers , 1981, Biopolymers.
[14] L. Hood,et al. A gas-liquid solid phase peptide and protein sequenator. , 1981, The Journal of biological chemistry.
[15] K. Nakamura,et al. Studies on a new proteolytic enzyme from Achromobacter lyticus M497-1. II. specificity and inhibition studies of Achromobacter protease I. , 1981, Biochimica et biophysica acta.
[16] M. Hermodson,et al. Separation of large denatured peptides by reverse phase high performance liquid chromatography. Trifluoroacetic acid as a peptide solvent. , 1980, The Journal of biological chemistry.
[17] K. Mann,et al. Primary structure of human prethrombin 2 and alpha-thrombin. , 1977, The Journal of biological chemistry.
[18] D. Hewett‐Emmett,et al. Amino acid sequence of human prothrombin fragments 1 and 2. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[19] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[20] A. Thompson,et al. Human thrombin: partial primary structure. , 1977, Archives of biochemistry and biophysics.
[21] K. Mann,et al. Human prothrombin activation. , 1975, The Journal of biological chemistry.
[22] H. Neurath,et al. Determination of the amino acid sequence of porcine trypsin by sequenator analysis , 1973 .